MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.cardfail.2018.02.009

Медицинская библиотека · Journal of cardiac failure · 2018

A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplant Mechanical Circulatory Support Outcomes in Cardiac Sarcoidosis.

Crawford Todd C, Okada David R, Magruder J Trent, Fraser Charles, Patel Nishant, Houston Brian A, Whitman Glenn J, Mandal Kaushik, Zehr Kenton J, Higgins Robert S, Chen Edward S, Tandri Hari, Kasper Edward K, Tedford Ryan J, Russell Stuart D, Gilotra Nisha A

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Patients with end-stage cardiomyopathy due to cardiac sarcoidosis (CS) may be referred for mechanical circulatory support (MCS) and heart transplantation (HT). We describe outcomes of patients with CS undergoing HT, focusing on the use of MCS as a bridge to transplant (BTT).

METHODS

Using the United Network for Organ Sharing Scientific Registry of Transplant Recipients, we identified all adult waitlisted patients and isolated HT recipients from 2006 to 2015. These were divided into those with and without CS and further divided into those who did or did not receive MCS as BTT. Outcomes included 1- and 5-year post-transplantation freedom from mortality and 5-year freedom from primary graft failure.

RESULTS

Over the study period, 31,528 patients were listed for HT, 148 (0.4%) of whom had CS. Among the CS patients, 34 (23%) received MCS as BTT. 18,348 patients (58%) eventually underwent HT, including 67 (0.4%) with CS, 20 (30%) of whom had received BTT MCS. Compared with non-CS diagnoses, CS patients had similar 1-year (91% vs 90%; log rank P = .88) and 5-year (83% vs 77%; log rank P = .46) freedom from mortality. Survival was also similar between CS BTT and non-CS BTT groups at 1 year (89% vs 89%; log-rank P = .92) and 5 years (72% vs 75%; log-rank P = .77).

CONCLUSIONS

Survivals after HT were similar between CS and non-CS patients out to 5 years, and were also similar between CS and non-CS BTT cohorts. Both HT and BTT MCS should be considered in patients with CS.

Для цитирования: Crawford Todd C, Okada David R, Magruder J Trent, Fraser Charles, Patel Nishant, Houston Brian A, Whitman Glenn J, Mandal Kaushik, Zehr Kenton J, Higgins Robert S, Chen Edward S, Tandri Hari, Kasper Edward K, Tedford Ryan J, Russell Stuart D, Gilotra Nisha A. A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplant Mechanical Circulatory Support Outcomes in Cardiac Sarcoidosis.. Journal of cardiac failure. 2018. DOI: 10.1016/j.cardfail.2018.02.009.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.